about
Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virusFull genomic analysis of an influenza A (H1N2) virus identified during 2009 pandemic in Eastern India: evidence of reassortment event between co-circulating A(H1N1)pdm09 and A/Brisbane/10/2007-like H3N2 strainsAvian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human populationMolecular insight into substrate recognition by human cytosolic sialidase NEU2Emergence of influenza A virusesPerspectives on antiviral use during pandemic influenzaExisting antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cellsInfluenza: emergence and controlInjectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutininModeling human influenza infection in the laboratorySafety and efficacy of peramivir for influenza treatmentBiochemical and structural assessment of the 1-N-azasugar GalNAc-isofagomine as a potent family 20 beta-N-acetylhexosaminidase inhibitorHighly Conserved Protective Epitopes on Influenza B VirusesReverse Genetics Approaches for the Development of Influenza VaccinesCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusA throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoVComparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialMutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemicImpact of different oseltamivir regimens on treating influenza A virus infection and resistance emergence: insights from a modelling studyThe N-terminal fragment of a PB2 subunit from the influenza A virus (A/Hong Kong/156/1997 H5N1) effectively inhibits RNP activity and viral replicationDesialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin bindingIncreased maternal consumption of methionine as its hydroxyl analog promoted neonatal intestinal growth without compromising maternal energy homeostasisPandemic influenza and healthcare demand in the Netherlands: scenario analysisDrug resistance in influenza A virus: the epidemiology and management.Progress of small molecular inhibitors in the development of anti-influenza virus agents.Planning for the next pandemic of influenza.New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.The treatment of influenza with antiviral drugsNovel strategies for prevention and treatment of influenza.Antiviral therapy of influenza.Influenza: lessons from past pandemics, warnings from current incidents.Avian flu: isolation of drug-resistant H5N1 virus.Model-based simulation and prediction of an antiviral strategy against influenza A infection.An iatrogenic pandemic of panic.Emergence of drug-resistant influenza virus: population dynamical considerations.Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors.Insights into the interaction between influenza virus and pneumococcus
P2860
Q21144425-62FF9644-8E9B-4EF7-81D2-005AAD858152Q21245092-BA26783F-B7F7-45F5-AF08-C31564127C15Q21245109-A2FCB3A4-D392-41F3-894E-035302B5FA17Q24301390-B597147F-48E4-44DB-BBE0-98B8938FEF62Q24522371-FB1B8508-EC7C-4A86-B35F-618C64A67A76Q24522384-BC5FFC5C-F780-4E49-A166-30DB74EBC2F9Q24536333-4AC272B7-6BC7-49F0-B978-29DBA3E73A44Q24559989-3D4646E3-F43B-4BA7-9F0A-C2D375608538Q24562911-2C56C9E1-5045-485D-8057-AFF6B7B277D0Q24645944-086083AE-A75B-402F-AD1E-9F682F3E0869Q24680353-C29C2B9C-AA82-4146-881A-A5C43583B32CQ26781842-663FD13D-405E-4F2C-B8DF-4D26EF712859Q27027408-1A226B84-9255-4C3F-80A6-B323D143172CQ27634390-1D4B67B1-CAF1-4A91-A0B8-2CEEDA0B6C1FQ27671404-75DCA537-163D-4F18-9129-1ACEE31126E8Q28076140-94FB30CA-7F80-4C96-A115-E30D3E4D656EQ28084005-FB6AAD84-9AEE-40A9-A53D-2AEAD0F66857Q28250266-08362C67-D478-491B-91E4-0D3B861950B2Q28364114-3C2C3A51-7488-4563-A673-2A3BD6D1204BQ28475986-8C967AD5-B2BC-4197-AE30-61F65FD70712Q28477952-D10F9534-DD9E-4309-82CF-9C5B143571CDQ28537982-CB5DAA95-9022-44CF-80DB-A81C7E99DDABQ28542440-0C67D944-DB21-4923-8194-A00B9F7E6C0DQ28588880-681BD2A7-FC1B-4B75-92D7-698FBC16B4AFQ28598187-AA88FFE9-E758-43E2-8C61-E60BF946BEFBQ30233416-F3C3D142-42CF-420A-94B6-2EB1B7E1B15FQ30234600-B176E178-1422-40D2-BCC1-F0043E58CC02Q30234943-2522F68D-32B1-454B-BF55-1C28FF321AF7Q30327977-3A358948-D34F-44C1-9CC4-4CBB4E647FFDQ30332341-51AF4A69-AC97-4A63-AB85-C6AC6DB4456EQ30332377-EC693D60-81F9-403D-BC7F-9B32F22325A1Q30350342-6064CDC8-1D19-4269-BEC1-96DCAC3A8B72Q30350565-EADF25DF-89C5-41FD-8FBA-3F845E2124A1Q30351160-0572EC23-C835-472D-A5B0-82D9D00A65C5Q30351638-E05FC307-1782-4F0C-997E-72E75EAA4B27Q30352246-4D312899-72D2-47FB-BEFD-E37363E6C9F6Q30353586-3522476D-001B-4A88-9D46-6B833F444525Q30353989-95BB656B-855C-4C6B-B6F1-82E00356D0BEQ30355434-E95A22E9-D636-4068-A279-11C94A044056Q30355570-F42C3AC3-CF1F-41C7-BCB0-0161E8088ED4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Influenza virus neuraminidase inhibitors.
@ast
Influenza virus neuraminidase inhibitors.
@en
type
label
Influenza virus neuraminidase inhibitors.
@ast
Influenza virus neuraminidase inhibitors.
@en
prefLabel
Influenza virus neuraminidase inhibitors.
@ast
Influenza virus neuraminidase inhibitors.
@en
P2093
P1433
P1476
Influenza virus neuraminidase inhibitors.
@en
P2093
F G Hayden
L V Gubareva
P304
P356
10.1016/S0140-6736(99)11433-8
P407
P577
2000-03-01T00:00:00Z